Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Baraliakos, Xenofon" or (type any "bookEditor journalEditor issueEditor" and editor="Bara...

Add to list
- Conference Paper
- C3
- open access
Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints : multicentre development and validation of diagnostic accuracy

Thomas Van Den Berghe (UGent) , Danilo Babin (UGent) , Min Chen, Martijn Callens, Denim Brack, Helena Maes, Jan Lievens, Marie Lammens, Maxime Van Sumere, Lieve Morbée (UGent) , et al.

(2023) 2023 ESSR Annual Scientific Meeting, Abstracts.
Add to list
MRI lesions of the spine in patients with axial spondyloarthritis : an update of lesion definitions and validation by the ASAS MRI working group

Xenofon Baraliakos, Mikkel Ostergaard, Robert G. W. Lambert, Iris Eshed, Pedro M. Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge (UGent) , Joachim Sieper, Denis Poddubnyy, et al.

(2022) ANNALS OF THE RHEUMATIC DISEASES. 81(9). p.1243-1251
Add to list
- Journal Article
- A1
- open access
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes : data from a large, prospective, observational cohort

Adrian Ciurea, Seraphina Kissling, Kristina Buerki, Xenofon Baraliakos, Manouk de Hooge (UGent) , Monika Hebeisen, Eleftherios Papagiannoulis, Pascale Exer, Rene Bram, Michael J. Nissen, et al.

(2022) RMD OPEN. 8(1).
Add to list
- Journal Article
- A1
- open access
Achievement of remission endpoints with secukinumab over 3 years in active ankylosing spondylitis : pooled analysis of two phase 3 studies

Xenofon Baraliakos, Filip Van den Bosch (UGent) , Pedro M. Machado, Lianne S. Gensler, Helena Marzo-Ortega, Bintu Sherif, Erhard Quebe-Fehling, Brian Porter, Corine Gaillez and Atul Deodhar

(2021) RHEUMATOLOGY AND THERAPY. 8(1). p.273-288
Add to list
- Journal Article
- A1
- open access
Secukinumab efficacy on enthesitis in patients with ankylosing spondylitis : pooled analysis of four pivotal phase III studies

Georg Schett, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Atul Deodhar, Mikkel Ostergaard, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Brian Porter, et al.

(2021) JOURNAL OF RHEUMATOLOGY. 48(8). p.1251-1258
Add to list
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Walter P. Maksymowych, Robert G. Lambert, Xenofon Baraliakos, Ulrich Weber, Pedro M. Machado, Susanne J. Pedersen, Manouk de Hooge (UGent) , Joachim Sieper, Stephanie Wichuk, Denis Poddubnyy, et al.

(2021) RHEUMATOLOGY. 60(10). p.4778-4789
Add to list
- Journal Article
- A1
- open access
Axial involvement in psoriatic arthritis cohort (AXIS) : the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Jurgen Braun, Laura C. Coates, Vinod Chandran, Torsten Diekhoff, Floris A. van Gaalen, Lianne S. Gensler, Niti Goel, et al.

(2021) THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 13.
Add to list
- Journal Article
- A1
- open access
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement

Peter Nash, Andreas Kerschbaumer, Thomas Doerner, Maxime Dougados, Roy M. Fleischmann, Klaus Geissler, Iain McInnes, Janet E. Pope, Desiree van der Heijde, Michaela Stoffer-Marx, et al.

(2021) ANNALS OF THE RHEUMATIC DISEASES. 80(1). p.71-87
Add to list
- Journal Article
- A1
- open access
Induction of sustained clinical remission in early axial spondyloarthritis following certolizumab pegol treatment : 48-week outcomes from C-OPTIMISE

Robert Landewe, Desiree van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Karl Gaffney, Lars Bauer, Bengt Hoepken, Natasha de Peyrecave, Karen Thomas, et al.

(2020) RHEUMATOLOGY AND THERAPY. 7(3). p.581-599
Add to list
- Journal Article
- A1
- open access
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction

Robert B. M. Landewe, Desiree van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Karl Gaffney, Lars Bauer, Bengt Hoepken, Owen R. Davies, Natasha de Peyrecave, et al.

(2020) ANNALS OF THE RHEUMATIC DISEASES. 79(7). p.920-928

Academic Bibliography

Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints : multicentre development and validation of diagnostic accuracy

MRI lesions of the spine in patients with axial spondyloarthritis : an update of lesion definitions and validation by the ASAS MRI working group

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes : data from a large, prospective, observational cohort

Achievement of remission endpoints with secukinumab over 3 years in active ankylosing spondylitis : pooled analysis of two phase 3 studies

Secukinumab efficacy on enthesitis in patients with ankylosing spondylitis : pooled analysis of four pivotal phase III studies

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Axial involvement in psoriatic arthritis cohort (AXIS) : the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement

Induction of sustained clinical remission in early axial spondyloarthritis following certolizumab pegol treatment : 48-week outcomes from C-OPTIMISE

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction

Contents

Support

Contact